Skip to main content

Table 4 Worst grade of toxicity across all cycles of therapy

From: Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

 

No toxicity

Grade 1

Grade 2

Grade 3

Grade 4

Dyesthesia

12.8%

70.9%

11.6%

4.7%

0%

Paresthesia

5.7%

66.3%

19.8%

7%

1.2%